Cargando…

Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()

OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Asselin, Caroline, Ducharme, Anique, Ntimbane, Thierry, Ruiz, Matthieu, Fortier, Annik, Guertin, Marie-Claude, Lavoie, Joël, Diaz, Ariel, Levy, Émile, Tardif, Jean-Claude, Des Rosiers, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909262/
https://www.ncbi.nlm.nih.gov/pubmed/24494189
http://dx.doi.org/10.1016/j.redox.2013.12.009
_version_ 1782301815333715968
author Asselin, Caroline
Ducharme, Anique
Ntimbane, Thierry
Ruiz, Matthieu
Fortier, Annik
Guertin, Marie-Claude
Lavoie, Joël
Diaz, Ariel
Levy, Émile
Tardif, Jean-Claude
Des Rosiers, Christine
author_facet Asselin, Caroline
Ducharme, Anique
Ntimbane, Thierry
Ruiz, Matthieu
Fortier, Annik
Guertin, Marie-Claude
Lavoie, Joël
Diaz, Ariel
Levy, Émile
Tardif, Jean-Claude
Des Rosiers, Christine
author_sort Asselin, Caroline
collection PubMed
description OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associated with those of its potential precursors, namely n-6 polyunsaturated fatty acids (PUFA). METHODS AND RESULTS: Circulating levels of 4HNE-P were evaluated by gas chromatography-mass spectrometry in 71 control subjects and 61 ambulatory symptomatic HF patients along with various other clinically- and biochemically-relevant parameters, including other oxidative stress markers, and total levels of fatty acids from all classes, which reflect both free and bound to cholesterol, phospholipids and triglycerides. All HF patients had severe systolic functional impairment despite receiving optimal evidence-based therapies. Compared to controls, HF patients displayed markedly lower circulating levels of HDL- and LDL-cholesterol, which are major PUFA carriers, as well as of PUFA of the n-6 series, specifically linoleic acid (LA; P=0.001). Circulating 4HNE-P in HF patients was similar to controls, albeit multiple regression analysis revealed that LA was the only factor that was significantly associated with circulating 4HNE-P in the entire population (R(2)=0.086; P=0.02). In HF patients only, 4HNE-P was even more strongly associated with LA (P=0.003) and HDL-cholesterol (p<0.0002). Our results demonstrate that 4HNE-P levels, expressed relative to HDL-cholesterol, increase as HDL-cholesterol plasma levels decrease in the HF group only. CONCLUSION: Results from this study emphasize the importance of considering changes in lipids and lipoproteins in the interpretation of measurements of lipid peroxidation products. Further studies appear warranted to explore the possibility that HDL-cholesterol particles may be a carrier of 4HNE adducts.
format Online
Article
Text
id pubmed-3909262
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-39092622014-02-03 Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() Asselin, Caroline Ducharme, Anique Ntimbane, Thierry Ruiz, Matthieu Fortier, Annik Guertin, Marie-Claude Lavoie, Joël Diaz, Ariel Levy, Émile Tardif, Jean-Claude Des Rosiers, Christine Redox Biol Research Paper OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associated with those of its potential precursors, namely n-6 polyunsaturated fatty acids (PUFA). METHODS AND RESULTS: Circulating levels of 4HNE-P were evaluated by gas chromatography-mass spectrometry in 71 control subjects and 61 ambulatory symptomatic HF patients along with various other clinically- and biochemically-relevant parameters, including other oxidative stress markers, and total levels of fatty acids from all classes, which reflect both free and bound to cholesterol, phospholipids and triglycerides. All HF patients had severe systolic functional impairment despite receiving optimal evidence-based therapies. Compared to controls, HF patients displayed markedly lower circulating levels of HDL- and LDL-cholesterol, which are major PUFA carriers, as well as of PUFA of the n-6 series, specifically linoleic acid (LA; P=0.001). Circulating 4HNE-P in HF patients was similar to controls, albeit multiple regression analysis revealed that LA was the only factor that was significantly associated with circulating 4HNE-P in the entire population (R(2)=0.086; P=0.02). In HF patients only, 4HNE-P was even more strongly associated with LA (P=0.003) and HDL-cholesterol (p<0.0002). Our results demonstrate that 4HNE-P levels, expressed relative to HDL-cholesterol, increase as HDL-cholesterol plasma levels decrease in the HF group only. CONCLUSION: Results from this study emphasize the importance of considering changes in lipids and lipoproteins in the interpretation of measurements of lipid peroxidation products. Further studies appear warranted to explore the possibility that HDL-cholesterol particles may be a carrier of 4HNE adducts. Elsevier 2013-12-18 /pmc/articles/PMC3909262/ /pubmed/24494189 http://dx.doi.org/10.1016/j.redox.2013.12.009 Text en © 2013 The Authors https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/3.0/) .
spellingShingle Research Paper
Asselin, Caroline
Ducharme, Anique
Ntimbane, Thierry
Ruiz, Matthieu
Fortier, Annik
Guertin, Marie-Claude
Lavoie, Joël
Diaz, Ariel
Levy, Émile
Tardif, Jean-Claude
Des Rosiers, Christine
Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title_full Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title_fullStr Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title_full_unstemmed Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title_short Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
title_sort circulating levels of linoleic acid and hdl-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909262/
https://www.ncbi.nlm.nih.gov/pubmed/24494189
http://dx.doi.org/10.1016/j.redox.2013.12.009
work_keys_str_mv AT asselincaroline circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT ducharmeanique circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT ntimbanethierry circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT ruizmatthieu circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT fortierannik circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT guertinmarieclaude circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT lavoiejoel circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT diazariel circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT levyemile circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT tardifjeanclaude circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure
AT desrosierschristine circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure